Fatigue affects 15-30% of patients starting tirzepatide, typically emerging within the first 4-8 weeks as the body adjusts to slowed gastric emptying and GLP-1 receptor activation
However, it's important to inform your healthcare provider about all medications and supplements you're currently taking
No physician oversight
The successful turning point for this dual therapy seems to be the substitution of conventional PPIs with a novel type of PPI, the potassium-competitive acid blocker, vonoprazan, that has a strong and durable inhibitory effect on acid secretion and generates a neutral environment in the stomach, suitable for H
Eventually, it can help reduce emotional eating
Rather than masking symptoms, peptides like NAD and BPC-157 and tb500 are designed to work at the cellular level to support repair, resilience, and longevity